Diabetes drug may activate molecule that triggers cancer growth
- PMID: 24802155
- DOI: 10.1002/cncr.28752
Diabetes drug may activate molecule that triggers cancer growth
Similar articles
-
Cancer research. Cancer prevention with a diabetes pill?Science. 2012 Jan 6;335(6064):29. doi: 10.1126/science.335.6064.29. Science. 2012. PMID: 22223788 No abstract available.
-
Metformin amplifies chemotherapy-induced AMPK activation and antitumoral growth.Clin Cancer Res. 2011 Jun 15;17(12):3993-4005. doi: 10.1158/1078-0432.CCR-10-2243. Epub 2011 May 4. Clin Cancer Res. 2011. PMID: 21543517
-
The antidiabetic drug metformin inhibits uterine leiomyoma cell proliferation via an AMP-activated protein kinase signaling pathway.Gynecol Endocrinol. 2013 Jan;29(1):87-90. doi: 10.3109/09513590.2012.706668. Epub 2012 Jul 26. Gynecol Endocrinol. 2013. PMID: 22835064
-
Obesity, hyperinsulinemia and breast cancer: novel targets and a novel role for metformin.Expert Rev Mol Diagn. 2010 May;10(4):509-19. doi: 10.1586/erm.10.22. Expert Rev Mol Diagn. 2010. PMID: 20465505 Review.
-
Anticancer effects of metformin and its potential use as a therapeutic agent for breast cancer.Future Oncol. 2011 Jun;7(6):727-36. doi: 10.2217/fon.11.49. Future Oncol. 2011. PMID: 21675836 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous